Utrecht
Netherlands
10
2021-10-21
8
2025-03-11
These are the the leading inventors for applications assigned to GENMAB B.V.:
GENMAB B.V. based in Utrecht, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-DR5 antibodies and methods of use thereof
#2 | 2021-08-05 ✅ Patent 12,338,289 granted on 2025-06-24ANTIBODY VARIANT COMBINATIONS AND USES THEREOF
#3 | 2021-06-03 ✅ Patent 12,049,512 granted on 2024-07-30Antibody variants and uses thereof
#4 | 2020-06-11 ✅ Patent 12,173,076 granted on 2024-12-24Polypeptide variants and uses thereof
#5 | 2020-04-23ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE
#6 | 2019-10-17 ✅ Patent 10,882,913 granted on 2021-01-05Anti-DR5 antibodies and methods of use thereof
#7 | 2019-09-12POLYPEPTIDE VARIANTS AND USES THEREOF
#8 | 2015-06-25 ✅ Patent 11,180,572 granted on 2021-11-23Dimeric protein with triple mutations
#9 | 2015-05-21 ✅ Patent 9,611,327 granted on 2017-04-04Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof
#10 | 2014-08-28 ✅ Patent 10,759,867 granted on 2020-09-01Antibody variants and uses thereof
Also check out GENMAB B.V.'s (Utrecht, Netherlands) applicant profile with 10 patent applications submitted.
76237 ⎘